Company Analysis

Xencor, Inc. (XNCR)

Nasdaq: XNCR · Pharmaceutical Preparations · Pasadena, CA · filing with the SEC since 2005
Grade5.1
◀ Past 4.3● Present 6.1▶ Future 4.6
1 est.

Who runs Xencor, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Dahiyat Bassil I
PRESIDENT & CEO. First filing Dec 2013, latest Mar 9, 2026, 21 filings in all.
Officers reporting now
4
of 12 people with a filing in the last fifteen months
Directors reporting now
8
23 people on the record since 2013
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Cornelissen Bart JanSR. VICE PRESIDENT & CFOApr 2024Nov 12, 20263 · $500,000
Dahiyat Bassil IPRESIDENT & CEODec 2013Mar 9, 20264 · $2.1M
Desjarlais John RSR. VICE PRESIDENT & CSODec 2013Mar 9, 20264 · $1.3M
Eckert CeliaSVP, GENERAL COUNSELSep 2019Mar 9, 20263 · $100,000
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Ranieri Richard JdirectorDec 2017Nov 12, 20263 · $3.3M
Deshaies Raymond JosephdirectorJul 2025Jul 8, 2026none
Feigal EllendirectorNov 2018Jul 8, 20261 · $100,000
Gorman Kevin CharlesdirectorApr 2017Jul 8, 20261 · $100,000
Gustafson Kurt AdirectorJul 2014Jul 8, 20261 · $100,000
Klencke BarbaradirectorSep 2023Jul 8, 2026none
Montgomery Alan BrucedirectorMar 2015Jul 8, 20261 · $100,000
Simpson Todd EdirectorMar 2025Jul 8, 2026none
Earlier names on the record12, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton XNCR · research, not advice